홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 바이오테크놀러지 > Promising Biotech Companies in Europe
카테고리
바이오테크놀러지 (1590)
게놈 창약 (202)
맞춤형의료 (51)
바이오마커 (154)
바이오매트리얼 (54)
바이오장비 (357)
분자표적치료(MTT) (131)
유전자 치료/RNAi (101)
재생의학 (124)
항체/면역 (191)
시장보고서

Promising Biotech Companies in Europe

리서치사 Frost & Sullivan
발행일 2009년 04월 상품코드 85571
페이지 정보
가격
US $ 6,500 ￦ 7,744,700 Web Access (Regional License)
US $ 7,000 ￦ 8,340,500 Hard Copy & Web Access (Regional License)


영문목차

Abstract

This research service aims to profile some of the promising biotech companies in Europe across different countries and segments.

Table of Contents

1. INTRODUCTION

Biotechnology Industry - Europe

  • Overview
  • Research and Development Process

Application Areas

  • Protein Therapeutics and Monoclonal Antibodies
  • Gene Therapy and Anti Sense

2. PROMISING COMPANIES - PROFILES

Profiles

  • Affibody
  • Antisoma
  • Astex Therapeutics
  • Bavarian Nordic
  • BioInvent
  • Biotage
  • Biovitrum
  • Crucell
  • Flamel Technologies
  • GPC Biotech
  • Immatics Biotechnologies
  • Innogenetics
  • Intercytex
  • Medigene
  • Merial
  • NeuroSearch
  • Novozymes
  • Renovo
  • Santaris Pharma
  • Sartorius Stedium Biotech
  • TopoTarget
  • Transgene
  • Vernalis

3. CONCLUSION

Future of Biotech in Europe

  • Biotechnology Post Recession - How will it Be Affected

4. DECISION SUPPORT DATABASES

Databases Used

  • Number of Biotechnology Companies
  • Pharmaceutical R&D Expenditure
  • EPO Biotechnology Patents
  • Government R & D Investment in Biotechnology
  • Venture Capital Investment in Biotechnology
Back to Top